HeseltineDDakkakMWoodhouseKMacdonaldIAPotterJF. The effect of caffeine on postprandial hypotension in the elderly. J Am Geriatr Soc1991; 39: 160–4.
3.
OnrotJGoldbergMRBiaggioniIHollisterASKincaidDRobetsonD. Hemodynamic and humoral effects of caffeine in autonomic failure: therapeutic implications for postprandial hypotension. N Engl J Med1985; 313: 549–54.
4.
HeseltineDEl-JabriMAhmedFKnoxJ. The effect of caffeine on postprandial blood pressure in the frail elderly. Postgrad Med J1991; 67: 543–7.
5.
LendersJWMMorreHLCSmitsPThienT. The effects of caffeine on the postprandial fall of blood pressure in the elderly. Age Ageing1988; 17: 23640.
6.
HeseltineDJamesOFWPotterJF. Caffeine and postprandial blood pressure changes in elderly people (letter). Age Ageing1989; 18: 211.
7.
LendersJ. Caffeine and postprandial blood pressure changes in elderly people. Letter to the editor-reply. Age Ageing1989; 18: 211.
8.
SmitsPThienTVan't LaarA. Circulatory effects of coffee in relation to the pharmacokinetics of caffeine. Am J Cardiol1985; 56: 958–63.
9.
Management of orthostatic hypotension. Lancet1987; 1: 197–8.
10.
BunkerMLMcWilliamsM. Caffeine content of common beverages. J Am Diet Assoc1979; 74: 28–32.
11.
HoustonCS. High altitude illness—disease with protean manifestations. JAMA1976; 236: 2193–5.
12.
JohnsonTSRockPB. Acute mountain sickness. N Engl J Med1988; 319: 841–5.
13.
HackettPHRennieD. The incidence, importance and prophylaxis of acute mountain sickness. Lancet1976; 2: 149–55.
14.
SinghIKhannaPKSrivastavaMCLalMRoySBSubramanyamCSV. Acute mountain sickness. N Engl J Med1969; 280: 175–84.
15.
HackettPHRoachRCWoodRAFoutchRGMeehanRTRennieD. Dexamethasone for prevention and treatment of acute mountain sickness. Aviat Space Environ Med1988; 59: 950–4.
16.
HirataKMasayumaSSaitoA. Obesity as risk factor for acute mountain sickness. Lancet1989; 2: 1040–1.
17.
Acetazolamide for acute mountain sickness. FDA Drug Bull1983; 13 (Nov): 27.
18.
FishmanRA. Brain edema. N Engl J Med1976; 293: 706–11.
19.
LeendersKLBeaneyRPBrooksDJLammertsmaAAHeatherJDMcKenzieCG. Dexamethasone treatment of brain tumor patients: effects on regional cerebral blood flow, blood volume and oxygen utilization. Neurology1985; 35: 1610–6.
20.
JohnsonTSRockPBFulcoCSTradLASparkRFMaherJT. Prevention of acute mountain sickness by dexamethasone. N Engl J Med1984; 310: 683–6.
21.
SampsonJBCymermanABurseRLMaherJTRockPB. Procedures for the measurement of acute mountain sickness. Aviat Space Environ Med1983; 54: 1063–73.
22.
LevineBDYoshimuraKKobayashiTFukushimaMShibamotoTUedaG. Dexamethasone in the treatment of acute mountain sickness. N Engl J Med1989; 321: 1707–13.
23.
FerrazziniGMaggioriniMKriemlerSBartschPOelzO. Successful treatment of acute mountain sickness with dexamethasone. Br Med J1987; 294: 1380–2.
24.
EllsworthAJMeyerEFLarsonEB. Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mt. Rainier. West J Med1991; 154: 289–93.
25.
EllsworthAJLarsonEBStricklandD. A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxis. Am J Med1987; 83: 1024–30.
26.
ZellSCGoodmanPH. Acetazolamide and dexamethasone in the prevention of acute mountain sickness. West J Med1988; 148: 541–5.
27.
RockPBJohnsonTSCymermanABurseRLFalkLJFulcoCS. Effect of dexamethasone on symptoms of acute mountain sickness at Pikes Peak, Colorado (4300m). Aviat Space Environ Med1987; 58: 668–72.
